Investors

Medicine has always been one of the most important branches of human life. This is because human health has always been among the highest values, the importance of which cannot be overstated.

Medicine is unthinkable without such a vital component as clinical research. Clinical studies provide an opportunity to bring innovation into medicine — any new drug must go through the research stage, without which market entry is impossible.

It should also be noted that the development of clinical research increases patient access to innovative drugs and drives economic growth by creating new jobs.

Clinical research has always been one of the longest and most expensive parts of the drug-development procedure. It is fair to say that roughly two-thirds of total drug-development spending goes directly into clinical research.

Our company understands the importance and value of clinical research for medicine, which is why one of the main directions of our activity is conducting various studies — clinical, preclinical and bioequivalence. Our company employs only truly highly qualified specialists with extensive research experience.

Typically, at least three parties participate in a clinical study: the company conducting the study, the treatment-and-prevention institutions and the patients, plus an investor.

Most often, clinical research is sponsored by pharmaceutical companies; however, more and more investors are entering this field, ready to invest in clinical research, since today it is genuinely a promising area for investment.

Speaking of the investment attractiveness of our company in the field of clinical research, the following strengths are worth noting:

- the company employs top-class specialists who have not only an excellent theoretical knowledge base but also a rich practical experience;

- you will not need to spend time or effort looking for volunteers. The company has built a database of volunteers who are ready to participate in clinical studies at any time. This database is constantly updated and expanded. Furthermore, every volunteer is selected according to specific criteria, which rules out participation of a volunteer in a study for which they are not suitable;

- high quality of clinical-research execution;

- fast turnaround;

- reliable results.

Our company is always open to collaboration with investors and offers the most attractive conditions for conducting clinical trials and registering medicines, dietary supplements and medical devices.